期刊文献+

阿托伐他汀及辅酶Q10对冠脉介入术后血清妊娠相关蛋白A及超敏C反应蛋白的影响 被引量:4

Effects of combination atorvastatin and coenzyme Q10 on plasma c-reactive protein and PAPP — A after percutaneous coronary intervention
下载PDF
导出
摘要 目的探讨阿托伐他汀与辅酶Q10联合应用对经皮冠脉介入(PCI)术后血清超敏C反应蛋白(hs-CRP)及妊娠相关蛋白A(PAPP-A)的影响。方法选取经PCI治疗单支病变的不稳定型心绞痛患者60例,随机分为对照组(n=20)、阿伐他汀组(n=20)和阿伐他汀+辅酶Q10组(联合组,n=20)。对照组采用常规治疗,阿伐他汀组采用常规治疗+阿托伐他汀(40mg,1次/晚),联合组采用常规治疗+阿托伐他汀(40mg,1次/晚)+辅酶Q10(10mg,tid)。测定所有患者术前、术后24h及术后30d的hs-CRP、PAPP-A水平。结果①所有组别术后24h和术后30d的hs-CRP、PAPP-A水平均较术前明显升高(P<0.05),但术后30d低于术后24h,差异有统计学意义(P<0.05);②与对照组比较,联合组和阿伐他汀组术后24h和术后30d的hs-CRP和PAPP-A水平均较低,差异有统计学意义(P<0.05);③与阿伐他汀组比较,联合组术后24h和30d的hs-CRP和PAPP-A水平均较低,差异有统计学意义(P<0.05)。结论阿托伐他丁与辅酶Q10具有协同抗炎作用。 Objective To investigate the influences of combination of atorvastatin and co-enzyme Q10 on serum high sensitivity C-reactive protein ( hs-CRP ) and pregnancy-associated plasma protein-A ( PAPP-A ) after percutaneous coronary intervention ( PCI ) . Methods The patients ( n =60 ) with unstable angina single vessel lesion treated with PCI were randomly divided into control group ( n =20 ) , atorvastatin group ( n =20 ) and atorvastatin combining co-enzyme Q10 group ( combining group, n =20 ) . The control group was treated with routine therapy, atorvastatin group, with atorvastatin ( 40 mg, once every night ) besides of routine therapy, and combining group, with atorvastatin ( 40 mg, once every night ) and co-enzyme Q10 ( 10 mg, three time a day ) besides of routine therapy. The levels of serum hs-CRP and PAPP-A were detected before PCI, and 24 hours and 30 days after PCI. Results ① The levels of serum hs-CRP and PAPP-A were higher in all groups 24 hours and 30 days after PCI than those before PCI ( P 0.05 ) , and were lower 30 days after PCI than those 24 hours after PCI ( P 0.05 ) . ② Compared with control group, the levels of serum hs-CRP and PAPP-A were lower in combining group and atorvastatin group 24 hours and 30 days after PCI ( P 0.05). ③ Compared with atorvastatin group, the levels of serum hs-CRP and PAPP-A were lower in combining group 24 hours and 30 days after PCI ( P 0.05). Conclusion After PCI the levels of serum hs-CRP and PAPP-A are all increased. Atorvastatin has the effect of reducing inflammatory level, which will be improved if atorvastatin is combined with co-enzyme Q10.
作者 刘英华
出处 《中国循证心血管医学杂志》 2012年第5期465-467,共3页 Chinese Journal of Evidence-Based Cardiovascular Medicine
关键词 经皮冠脉介入术 超敏C-反应蛋白 妊娠相关蛋白A 阿托伐他汀 辅酶Q10 Coronary diseases Percutaneous coronary intervention high-sensitive C-reactive protein Pregnancy-associated plasma protein-A Antilipemic agents Co-enzyme Q10
  • 引文网络
  • 相关文献

参考文献11

  • 1Lim SYJeong MH’Bae EH,ei al ? Predictive factors of major adversecardiac events in acute myocardial infarction patients complicatedby cardiogenic shock undergoing primary percutaneous coronaryintervention^]. Girc J,2005,69(2):154-8.
  • 2刘志远,张金盈,李纲,韩学华,李玉东.妊娠相关蛋白-A与冠状动脉斑块形态关系的临床研究[J].中国心血管病研究,2007,5(9):641-643. 被引量:4
  • 3Ray KK,Nazer B,Caims R成 cd. Association between percutaneous coronaryintervention and long-term C—reactive protein levels in patients with acutecoronary syndromesfj]. J Thromb Thrombolysis,2010,30(1):10-3.
  • 4Stefanadis C,Toutouzas K’Tsiamis E,扣 al. Relation between localtemperature and C-reactive protein levels in patients with coronaryartery disease:e?fects of atorvastatin treatment[J]. Atherosclerosis,2007,192(2):396-400.
  • 5Bourassil MG,Mdarman EL,Bemand M,ei al. The International Societyand FeAeration of Cardiology and the World Health Organization[J].Circulation,2007,142(7):780-9.
  • 6Ross R.Atherosclerosis-an intlanunatory disease[J]. N Engl JMed,1999,340(2):115-26.
  • 7Irfan G,Ahmad M. Highly sensitive C-reactive protein concentrationand angiographic characteristics of coronary lesion[J]. J Ayub MedColl Abbottabad,2008,20(3): 100-3.
  • 8Sambu N,Dent H,Englyst N,et al. Effect of clopidogrel withdrawal onplatelet reactivity and vascular inflammatory biomarkers 1 year afterdrug-eluting stent implantation:results of the prospective,single-centre CESSATION study[J]. Heart, 2011,97(20):1661-7.
  • 9Anghnvi M,Libby P,Falk E,ef al. From vulnerable plaque tovulnerable patient:a call for new definitions and risk assessmentstrategies:Part II [J]. Circulation,2003,10(8): 1772-8.
  • 10Sun Y,Qi G,Gao Y,et al. Effect of different loading doses ofatorvastatin on percutaneous coronary intervention for acute coronarysyndromes[J]. Can J Cardiol,2010,26(9):481-5.

二级参考文献16

  • 1韩雅玲,臧红云,荆全民,王守力,王冬梅,王祖禄.冠心病合并慢性肾功能不全介入诊断或治疗围术期的肾功能保护[J].中国危重病急救医学,2004,16(9):530-532. 被引量:14
  • 2梅卫义,杜志民,胡承恒,张辉,李怡,罗初凡,陈国伟.不稳定型心绞痛患者妊娠相关血浆蛋白A与高敏C反应蛋白的相关性[J].中国动脉硬化杂志,2005,13(2):207-209. 被引量:16
  • 3缪京莉,侯晓平,尹巧香,靳英,周云飞,张婧.非离子型造影剂对老年冠心病患者肾功能的影响[J].中国临床保健杂志,2007,10(4):364-366. 被引量:4
  • 4[1]Depre C,Wijns W,Robert AM,et al.Pathology of unstable plaque correlation with the clinical severity of acute coronary syndromes.J Am Coll Cardiol,1997,30:694-702.
  • 5[2]Ambrose JA,Winters SL,Stem A,et al.Angiographic morphology and the path-ogenesis of unstable angina pectoris.J Am Coll Cardiol,1985,5:609.
  • 6[3]Bayes-Genis A,Conover CA,Overgard MT,et al.Pregnancy-associated plasma protein A as a marker of acute coronary syndromes.N Engl J Med,2001,345:1022-1029.
  • 7[5]Lawrence JB,Oxvig C,Overgaard MT,et al.The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A.Proc Natl Acad Sci USA,1999,16:3149-3153.
  • 8[6]Overgaard MT,Boldt IIB,Laursen LS,et al.Pregnancy-associated plasma protein-A (PAPP-A),a novel insulin-like growth factor-binding protein-5 proteinase.J Biol Chem,2001,276:21849-21853.
  • 9[7]Beaudeu JL,Burc L,Imbert-Bismut F,et al.Serum pregnancyassociated plasma protein A:a potential merbeir of echogenic of echogenic carotid at herosclerotic plaques in asymptomatic hyparlipidemic subjects at high cardiovascular risk.Artheroscler Thrombo Vasc Biol,2003,23:7-10.
  • 10[8]Monrone S,Parilak L,Kerensky R.angiographic patterns and the natural history of the vulnerable plaque.Prog Cardiovasc Dis,2002,72:341-342.

共引文献14

同被引文献20

二级引证文献28

;
使用帮助 返回顶部